190 related articles for article (PubMed ID: 12206842)
1. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer.
Bahn DK; Lee F; Badalament R; Kumar A; Greski J; Chernick M
Urology; 2002 Aug; 60(2 Suppl 1):3-11. PubMed ID: 12206842
[TBL] [Abstract][Full Text] [Related]
2. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
3. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
Dhar N; Ward JF; Cher ML; Jones JS
BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
[TBL] [Abstract][Full Text] [Related]
4. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up.
Bahn DK; Lee F; Silverman P; Bahn E; Badalament R; Kumar A; Greski J; Rewcastle JC
Clin Prostate Cancer; 2003 Sep; 2(2):111-4. PubMed ID: 15040872
[TBL] [Abstract][Full Text] [Related]
5. Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.
Ellis RJ; Vertocnik A; Kim E; Zhou H; Young B; Sodee B; Fu P; Beddar S; Colussi V; Spirnak JP; Dinchman KH; Resnick M; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):362-70. PubMed ID: 12957246
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
[TBL] [Abstract][Full Text] [Related]
7. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
8. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
9. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
Ismail M; Ahmed S; Kastner C; Davies J
BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
[TBL] [Abstract][Full Text] [Related]
10. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
11. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
12. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
13. Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer.
DiBlasio CJ; Derweesh IH; Malcolm JB; Maddox MM; Aleman MA; Wake RW
Int Braz J Urol; 2008; 34(4):443-50. PubMed ID: 18778495
[TBL] [Abstract][Full Text] [Related]
14. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
Ng CK; Moussa M; Downey DB; Chin JL
J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
[TBL] [Abstract][Full Text] [Related]
16. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
[TBL] [Abstract][Full Text] [Related]
17. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution.
Martinez AA; Gonzalez JA; Chung AK; Kestin LL; Balasubramaniam M; Diokno AC; Ziaja EL; Brabbins DS; Vicini FA
Cancer; 2000 Jan; 88(2):425-32. PubMed ID: 10640977
[TBL] [Abstract][Full Text] [Related]
18. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).
Chin JL; Al-Zahrani AA; Autran-Gomez AM; Williams AK; Bauman G
J Urol; 2012 Oct; 188(4):1170-5. PubMed ID: 22901586
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.
Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS
World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729
[TBL] [Abstract][Full Text] [Related]
20. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS
Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
